Skip to content

Efficacy Evaluation of Directly Printed Aligners in the Treatment of Malocclusion: A Multicenter, Prospective Observational Cohort Study

Efficacy Evaluation of Directly Printed Aligners in the Treatment of Malocclusion: A Multicenter, Prospective Observational Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102828
Enrollment
Unknown
Registered
2025-05-20
Start date
2025-05-31
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malocclusion

Interventions

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Age Criteria 6-55 years (2) Diagnostic Inclusion Diagnosis of at least one of the following nine complex malocclusion types: a. Overjet b. Crossbite c. Deep overbite d. Bimaxillary protrusion e. Dental crowding f. Diastema g. Open bite h. Laterognathism i. Orthodontic management for cleft lip/palate (3) Good Compliance Requirements (4) Oral Health Criteria Optimal periodontal status: Bleeding on probing (BOP) <15% of sites Clinical attachment loss <= 2 mm Absence of: Gingival inflammation/edema Pathologic alveolar bone resorption Periapical lesions Maintained oral hygiene (5) Exclusion Criteria Systemic conditions affecting treatment outcomes: Uncontrolled hypertension Diabetes mellitus Cardiovascular diseases Autoimmune/immune system disorders Metabolic bone diseases

Exclusion criteria

Exclusion criteria: (1) Allergy-related Exclusions History of hypersensitivity reactions or atopic predisposition Documented allergy to polyurethane acrylate materials Persistent intolerance to foreign body sensation (VAS score >= 7/10) (2) Pharmacological Exclusions Chronic systemic corticosteroid use (>30 consecutive days) Immunomodulatory agent administration during study period or within one year preceding enrollment (3) Clinical Trial Participation Enrollment in other dental material clinical trials within three months prior to study participation (4) Protocol Non-compliance Risks Anticipated inability to adhere to follow-up schedules Potential compromise to scientific validity or data integrity (5) Systemic Disease Exclusions Active rheumatoid arthritis (DAS28 >3.2) Uncontrolled diabetes mellitus (HbA1c >8%) Osteoporosis (T-score 10 cigarettes/day) with refusal to cease use during study (8) Behavioral Exclusions Documented history of non-compliance with therapeutic protocols or follow-up requirements (9) Reproductive Status Exclusions Preconception planning phase Current pregnancy (ß-hCG confirmed) Lactation period (10) TMJ Disorder Exclusion Severe temporomandibular joint disorder syndrome (DC/TMD Criteria Grade III) (11) Discretionary Exclusion Other conditions deemed contraindicated by investigators based on: Clinical judgment Emerging safety data Unforeseen risk-benefit profile

Design outcomes

Primary

MeasureTime frame
Expression of orthodontic tooth movement;Real tooth movement amount;Predicted tooth movement amount;

Secondary

MeasureTime frame
Root resorption;Alveolar bone thickness;Gingival crevicular fluid detection;VAS score;Patient satisfaction assessment;Doctor satisfaction assessment;

Countries

China

Contacts

Public ContactFang Bing

Department of Orthodontics, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

fangbing@sjtu.edu.cn+86 137 6447 1988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026